Free Trial

Bright Health Group (BHG) Competitors

Bright Health Group logo
$6.75 +0.08 (+1.24%)
As of 10/1/2025

BHG vs. CRBU, BDTX, INFU, SGMO, ACRS, EPRX, HCAT, ELMD, CVRX, and UTMD

Should you be buying Bright Health Group stock or one of its competitors? The main competitors of Bright Health Group include Caribou Biosciences (CRBU), Black Diamond Therapeutics (BDTX), InfuSystem (INFU), Sangamo Therapeutics (SGMO), Aclaris Therapeutics (ACRS), Eupraxia Pharmaceuticals (EPRX), Health Catalyst (HCAT), Electromed (ELMD), CVRx (CVRX), and Utah Medical Products (UTMD). These companies are all part of the "medical" sector.

Bright Health Group vs. Its Competitors

Bright Health Group (NYSE:BHG) and Caribou Biosciences (NASDAQ:CRBU) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, media sentiment, profitability, dividends, valuation, institutional ownership and earnings.

Bright Health Group has a net margin of -85.40% compared to Caribou Biosciences' net margin of -1,800.93%. Bright Health Group's return on equity of 0.00% beat Caribou Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Bright Health Group-85.40% N/A -10.26%
Caribou Biosciences -1,800.93%-62.35%-49.65%

Bright Health Group has a beta of 0.93, indicating that its share price is 7% less volatile than the S&P 500. Comparatively, Caribou Biosciences has a beta of 2.59, indicating that its share price is 159% more volatile than the S&P 500.

Caribou Biosciences has a consensus target price of $6.67, suggesting a potential upside of 142.42%. Given Caribou Biosciences' stronger consensus rating and higher possible upside, analysts plainly believe Caribou Biosciences is more favorable than Bright Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bright Health Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Caribou Biosciences
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Caribou Biosciences has lower revenue, but higher earnings than Bright Health Group. Caribou Biosciences is trading at a lower price-to-earnings ratio than Bright Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bright Health Group$2.76B0.02-$1.46B-$208.73-0.03
Caribou Biosciences$9.99M25.63-$149.10M-$1.78-1.54

In the previous week, Caribou Biosciences had 3 more articles in the media than Bright Health Group. MarketBeat recorded 3 mentions for Caribou Biosciences and 0 mentions for Bright Health Group. Caribou Biosciences' average media sentiment score of 0.83 beat Bright Health Group's score of 0.00 indicating that Caribou Biosciences is being referred to more favorably in the news media.

Company Overall Sentiment
Bright Health Group Neutral
Caribou Biosciences Positive

77.5% of Caribou Biosciences shares are owned by institutional investors. 58.4% of Bright Health Group shares are owned by company insiders. Comparatively, 8.3% of Caribou Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Caribou Biosciences beats Bright Health Group on 10 of the 16 factors compared between the two stocks.

Get Bright Health Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for BHG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BHG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BHG vs. The Competition

MetricBright Health GroupHospital & medical service plans IndustryMedical SectorNYSE Exchange
Market Cap$53.90M$53.90M$6.14B$22.07B
Dividend YieldN/AN/A5.66%3.58%
P/E Ratio-0.03N/A85.7229.59
Price / Sales0.020.02631.4564.76
Price / CashN/AN/A38.3224.53
Price / Book-0.27N/A13.094.61
Net Income-$1.46B-$1.46B$3.30B$1.01B
7 Day PerformanceN/AN/A3.75%-0.98%
1 Month Performance0.04%0.04%10.73%2.51%
1 Year Performance21.52%21.52%85.28%14.61%

Bright Health Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BHG
Bright Health Group
N/A$6.75
+1.2%
N/A+21.5%$53.90M$2.76B-0.032,840
CRBU
Caribou Biosciences
2.2209 of 5 stars
$2.33
+1.3%
$6.67
+186.1%
+48.6%$214.18M$9.99M-1.31100News Coverage
Analyst Forecast
Gap Up
BDTX
Black Diamond Therapeutics
3.5468 of 5 stars
$3.79
+1.6%
$11.00
+190.2%
+21.7%$212.37MN/A16.4890News Coverage
Positive News
Analyst Forecast
INFU
InfuSystem
4.5456 of 5 stars
$10.36
-1.3%
$13.50
+30.3%
+41.7%$211.61M$139.89M172.70410
SGMO
Sangamo Therapeutics
2.214 of 5 stars
$0.67
-3.8%
$4.50
+568.3%
-6.5%$211.20M$57.80M-2.32480News Coverage
Analyst Forecast
ACRS
Aclaris Therapeutics
2.5577 of 5 stars
$1.90
-1.0%
$8.71
+358.6%
+66.7%$208M$18.72M-1.39100Positive News
High Trading Volume
EPRX
Eupraxia Pharmaceuticals
2.7929 of 5 stars
$5.90
+2.6%
$11.00
+86.4%
+166.8%$206.77MN/A-6.9429Analyst Forecast
HCAT
Health Catalyst
4.1787 of 5 stars
$2.85
-2.4%
$4.73
+65.9%
-64.9%$205.49M$306.58M-1.891,500News Coverage
Analyst Forecast
ELMD
Electromed
3.734 of 5 stars
$24.55
+0.0%
$36.25
+47.7%
+15.4%$204.97M$64M32.73160
CVRX
CVRx
2.6831 of 5 stars
$8.07
+3.7%
$14.00
+73.5%
+20.1%$203.46M$51.29M-3.84160News Coverage
Positive News
Analyst Forecast
UTMD
Utah Medical Products
2.3203 of 5 stars
$62.97
+0.4%
N/A-4.2%$201.06M$40.90M16.84180News Coverage
Analyst Forecast

Related Companies and Tools


This page (NYSE:BHG) was last updated on 10/10/2025 by MarketBeat.com Staff
From Our Partners